10 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.
Xoma Corp (XOMA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,530,543 | $98,785 | 3.95% | |
| 2. | Opaleye Management James A. Silverman | 271,000 | $7,583 | -20% | 2.35% |
| 3. | Stonepine Capital Timothy P. Lynch | 36,803 | $1,030 | -21% | 0.42% |
| 4. | Millennium Management Israel Englander | 25,111 | $703 | -4% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 200,000 | Director, Other | 200,000 | 2020-12-11 | Filing | |
| $25.00 | 200,000 | Large Shareholder, Director, Other | 200,000 | 2020-12-11 | Filing | |
| $18.20 | 7,201 | Large Shareholder, Director, Other | 1,750,704 | 2020-09-23 | Filing | |
| $18.45 | 4,991 | Large Shareholder, Director, Other | 1,743,503 | 2020-09-22 | Filing | |
| $18.39 | 10,069 | Large Shareholder, Director, Other | 1,738,512 | 2020-09-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.02 | 1,111 | 11,822 | 2022-03-23 | Filing | ||
| $30.02 | 2,339 | 11,822 | 2022-03-22 | Filing | ||
| $29.01 | 50,000 | 11,822 | 2022-03-21 | Filing | ||
| $30.00 | 161 | 6,555 | 2022-03-23 | Filing | ||
| $30.02 | 2,339 | 6,555 | 2022-03-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,347 | $37,689 | 0% | |
| 2. | 938,481 | $26,259 | 0% | |
| 3. | 461,495 | $12,912 | 0% | |
| 4. | 405,118 | $11,336 | 0% | |
| 5. | 148,691 | $4,160 | 0% |
News See All
10 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
10 Pharmaceutical Stocks to Buy According to Timothy Lynch’s Stonepine Capital
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital.
Is XOMA Corp (XOMA) A Good Stock To Buy?
In this article we will check out the progression of hedge fund sentiment towards XOMA Corp (NASDAQ:XOMA) and determine whether it is a good investment right now.
Is XOMA A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Hedge Funds Are Souring On XOMA Corp (XOMA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Should You Avoid XOMA Corp (XOMA)?
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Hedge Fund and Insider Trading News: Mike Novogratz, David Abrams, Novume Solutions Inc (NVMM), XOMA Corp (XOMA), TPI Composites Inc (TPIC), and More
No one on Wall Street embraced cryptocurrencies with as much gusto as legendary trader Mike Novogratz.
Here’s What You Should Know About The Finance World Today
"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market.
How XOMA Corp (XOMA) Stacks Up Against Its Peers
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Billionaire Hedge Funds
